Denver, United States
Exer AI, founded in 2019, is paving the way for advancements in healthcare through its innovative use of Artificial Intelligence and computer vision. Specializing in musculoskeletal (MSK) and motion disorders, their platform enhances diagnostic and treatment processes by offering accurate motion assessments without the need for sensors or wearables. This versatility enables effective application in both in-person and remote sessions, addressing complex care needs across various medical disciplines, including orthopedics, neurology, and geriatrics.
Operating from the United States, Exer AI has been making significant strides in the healthcare sector, as evidenced by their successful $6.50M Seed Round investment in November 2022. The investment was led by notable investors like Backstage Capital, Morado Ventures, and Life Extension Ventures. Exer AI's focus on improving quality and efficiency in healthcare aligns well with the growing demand for innovative solutions in the sector, positioning it as a strong candidate for future growth and investment opportunities.
